Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula

Gastro-Intestinal Tolerance Clinical Trial

Official title:
Tolerance in Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula With Oligosaccharides

Status Terminated

Clinical Trial Summary

To assess the effects of partially hydrolyzed whey protein-based infant formula with oligosaccharides on symptoms of formula intolerance in healthy, term infants.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Gastro-Intestinal Tolerance

Clinical Trial Details

NCT number	NCT04934397
Study type	Interventional
Source	Abbott Nutrition
Contact
Status	Terminated
Phase	N/A
Start date	July 8, 2021
Completion date	February 18, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03293706` - Evaluation of Carbohydrates Part 2	N/A
Completed	`NCT01781624` - Evaluation of an Oral Nutritional Supplement	N/A
Completed	`NCT01782456` - Tolerance of an Oral Nutritional Supplement(ONS)	N/A
Completed	`NCT04259437` - Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With or at Risk of Malnutrition	N/A
Completed	`NCT03967132` - Growth and Tolerance of Infants Fed Milk-Based Infant Formula	N/A
Completed	`NCT04915937` - Formula Tolerance of Term Infants	N/A
Withdrawn	`NCT04104815` - GI Tolerance and Acceptability of a New Thickener	N/A